- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medasys-Japan Licenses iPACS
RealTimeImage, a provider of Internet-based streaming solutions, has entered a licensing agreement with Medasys-Japan, a
RealTimeImage, a provider of Internet-based streaming solutions, has entered a licensing agreement with Medasys-Japan, a developer and marketer of PACS. Under the agreement, Medasys will integrate RealTime's iPACS Enterprise into its DICOM-server products. The iPACS products allow immediate access to lossless diagnostic-quality images and image sequences over a wide range of bandwidths from simple telephone lines to fast LANs. No preprocessing or intermediate storage is required. Medasys-Japan has a large installed base of DICOM image viewer and teleradiology products. Founded in 1997 in Tokyo, Medasys-Japan is a division of Medasys, SA, headquartered in France, which develops PACS and electronic medical record and radiology information systems.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
